J&J Expands New Drug Portfolio With Icotyde's FDA Approval
unknown
📅 Published: 2026-03-19 16:11
📰 Source: Yahoo
📝 Words: 24
📝 Article Content
J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.
📄 Summary
J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-03-20 04:09:37
Updated At:
2026-03-20 04:09:37
Scraping Job ID:
N/A
Stock Mentions:
KEY - KeyCorp
Relevance: N/A